Publications:  Prof Nicholas Croft

Tan ZV, Kosana K, Savarino J, Croft N, Naik S, Kaplan J, Giles E(2020). Histology at diagnostic gastroscopy predicts outcome after intestinal resection in pediatric Crohn's disease. J Gastroenterol Hepatol

Croft N(2020). Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease. Nature Communications vol. 11, Article 995,

Aardoom M, Kemos P, Ruemmele FM, van Ommen CH, Croft NM, de Ridder L, PIBDnet P-SC (2020). The occurrence of venous thromboembolisms in paediatric-onset IBD. JOURNAL OF CROHNS & COLITIS. vol. 14, S194-S194.

Sazonovs A, Kennedy NA, Moutsianas L, Heap GA, Rice DL, Reppell M, Bewshea CM, Chanchlani N et al.(2019). HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease. Gastroenterology vol. 158, (1) 189-199.

De Jesus H, Ooms A, Norton C, Dibley L, Croft N(2019). Development of self-management in pediatric inflammatory bowel disease: A qualitative exploration. Journal of Nursing Education and Practice vol. 9, (11) 75-75.

Krauthammer A, Tzivinikos C, Assa A, Miele E, Strisciuglio C, Urlep D, Serban ED, Singh A et al.(2019). Long-term Outcomes of Paediatric Patients Admitted with Acute Severe Colitis - A Multicenter Study from the Paediatric IBD Porto Group of ESPGHAN. J Crohns Colitis

Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R et al.(2019). Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study. The Lancet Gastroenterology and Hepatology vol. 4, (5) 341-353.

Walker GJ, Harrison JW, Heap GA, Voskuil MD, Andersen V, Anderson CA, Ananthakrishnan AN, Barrett JC et al.(2019). Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease. JAMA vol. 321, (8) 773-785.

Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M et al.(2018). Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr vol. 67, (2) 257-291.

Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M et al.(2018). Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr vol. 67, (2) 292-310.

Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, Carpi JMD, Bronsky J, Veres G, Aloi M et al.(2018). Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis; An Evidence-based Consensus Guideline from ECCO and ESPGHAN. J Pediatr Gastroenterol Nutr

Auth MK-K, Bunn SK, Protheroe AL, Williams LJ, Fell JM, Muhammed R, Croft NM, Beattie RM et al.(2018). Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom. Inflamm Bowel Dis vol. 24(7), (Jun 8) 1520-1530.

Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MKH, Elawad M, Fell JME, Beattie RM et al.(2018). Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response. J Pediatr Gastroenterol Nutr vol. 66, (2) 274-280.

Wang S, Younus O, Rawat D, Naik S, Giles E, Meadows N, Croft NM(2017). Clinical Presentation and Outcomes of Diagnostic Endoscopy in Newly Presenting Children with Gastrointestinal Symptoms. J Pediatr Gastroenterol Nutr

Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MK, Elawad M, Fell JM, Beattie RM et al.(2017). Real-Life Anti-Tumour Necrosis Factor Experience in > 500 Paediatric United Kingdom Inflammatory Bowel Disease Patients. J Pediatr Gastroenterol Nutr

CROFT NM, GILES E(2017). Autoimmune Gastropathy. Esophageal and Gastric Disorders in Infancy and Childhood, Springer

Marcovitch L, Nissan A, Mack D, Otley A, Hussey S, Mclean B, Lewis M, Croft N et al.(2017). Item Generation and Reduction Toward Developing a Patient-reported Outcome for Pediatric Ulcerative Colitis (TUMMY-UC). J Pediatr Gastroenterol Nutr vol. 64, (3) 373-377.

Tranter M, Barakat F, Dogra H, Lindsay J, Croft N, Bulmer D (2017). MMP-12, a novel mediator of nociception in Crohn's disease. JOURNAL OF CROHNS & COLITIS. Conference: European Crohn's and Colitis (ECCO) Congress 2017 vol. 11, S120-S120.

Tranter M, Barakat F, Dogra H, Lindsay J, Croft N, Bulmer D (2017). P086 MMP-12, a novel mediator of nociception in Crohn's disease. J Crohns Colitis. vol. 11, S120-S120.

Croft N, Faubion W, Tierens D, Dewulf J, Bwirire D, Stefani-Hunyady D, Cataldi F (2016). Indication-specific feasibility assessment of a placebo-controlled randomised mesalazine withdrawal study for paediatric patients with ulcerative colitis. JOURNAL OF CROHNS & COLITIS. vol. 10, S336-S337.

Tranter M, Barakat F, Bulmer D, Croft N (2015). How do IBD supernatants activate visceral sensory afferents?. NEUROGASTROENTEROLOGY AND MOTILITY. vol. 27, 104-104.

Mt-Isa S, Tomlin S, Sutcliffe A, Underwood M, Williamson P, Croft NM, Ashby D(2015). Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide. J Pediatr Gastroenterol Nutr vol. 60, (4) 508-514.

Johal A, Abed Al Jawad F, Marcenes W, Croft N(2013). Does orthodontic treatment harm children's diets?. J Dent vol. 41, (11) 949-954.

Goodhand JR, Kamperidis N, Sirwan B, Macken L, Tshuma N, Koodun Y, Chowdhury FA, Croft NM et al.(2013). Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease. Aliment Pharmacol Ther vol. 38, (9) 1097-1108.

Russell RK, Protheroe A, Roughton M, Croft NM, Murphy MS, Spray C, Rodrigues AF, Wilson DC et al.(2013). Contemporary outcomes for ulcerative colitis inpatients admitted to pediatric hospitals in the United Kingdom. Inflamm Bowel Dis vol. 19, (7) 1434-1440.

Sebastian S, Jenkins H, McCartney S, Ahmad T, Arnott I, Croft N, Russell R, Lindsay JO(2012). The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and paediatric gastroenterologists. JOURNAL OF CROHNS & COLITIS vol. 6, (8) 830-844.

Al Jawad FA, Cunningham SJ, Croft N, Johal A(2012). A qualitative study of the early effects of fixed orthodontic treatment on dietary intake and behaviour in adolescent patients. EUROPEAN JOURNAL OF ORTHODONTICS vol. 34, (4) 432-436.

Russell RK, Protheroe A, Roughton M, Croft N, Murphy MS, Spray C, Rodrigues A, Wilson DC et al. (2012). INPATIENT PAEDIATRIC UC CARE IN THE UK IN 2011 IS CHARACTERISED BY INCREASING RATES OF RESCUE THERAPY AND STOOL CULTURES BUT LOW USE OF PUCAI SCORES. GUT. vol. 61, A22-A22.

Rao A, Kamperidis N, Koodun Y, Naik S, Croft NM, Sanderson IR (2012). RESPONSE TO ENTERAL NUTRITION PREDICTS INCREASED LENGTH OF REMISSION IN CHILDREN WITH CROHN'S DISEASE. GUT. vol. 61, A239-A239.

Giles E, Hanci O, McLean A, Power N, Cole A, Croft NM, McDonald K, Chippington S et al.(2012). Optimal assessment of paediatric IBD with MRI and barium follow-through. J Pediatr Gastroenterol Nutr vol. 54, (6) 758-762.

Kamperidis N, Goodhand JR, Chowdhury FA, Koodun Y, Direzke NC, Naik S, Sanderson IR, Croft NM et al.(2012). Factors associated with nonadherence to thiopurines in adolescent and adult patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr vol. 54, (5) 685-689.

Goodhand JR, Kamperidis N, Joshi NM, Wahed M, Koodun Y, Cantor EJ, Croft NM, Langmead FL et al.(2012). The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent. Aliment Pharmacol Ther vol. 35, (8) 929-940.

Goodhand JR, Kamperidis N, Rao A, Laskaratos F, McDermott A, Wahed M, Naik S, Croft NM et al.(2012). Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis vol. 18, (3) 513-519.

Houston Y, Lindsay JO, Jenkins H, McCartney S, Ahmad T, Arnott I, Croft N, Russell R et al.(2012). Perspectives of transition care in inflammatory bowel disease: A survey. Gastrointestinal Nursing vol. 10, (1) 30-35.

Goodhand J, Hedin CR, Croft NM, Lindsay JO(2011). Adolescents with IBD: the importance of structured transition care. J Crohns Colitis vol. 5, (6) 509-519.

Goodhand JR, Tshuma N, Rao A, Kotta S, Wahed M, Croft NM, Sanderson IR, Epstein J et al.(2011). Do children with IBD really respond better than adults to thiopurines?. J Pediatr Gastroenterol Nutr vol. 52, (6) 702-707.

Sebastian S, Jenkins H, Arnott I, Croft N, Ahmad T, McCartney S, Russell RK, Lindsay JO (2011). BARRIERS TO TRANSITION CARE IN INFLAMMATORY BOWEL DISEASE: A SURVEY OF ADULT AND PAEDIATRIC GASTROENTEROLOGISTS IN THE UK. GUT. vol. 60,

Vossenkämper A, Marchès O, Fairclough PD, Warnes G, Stagg AJ, Lindsay JO, Evans PC, Luong LA et al.(2010). Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE. J Immunol vol. 185, (7) 4118-4127.

Goodhand J, Dawson R, Hefferon M, Tshuma N, Swanson G, Wahed M, Croft NM, Lindsay JO(2010). Inflammatory bowel disease in young people: the case for transitional clinics. Inflamm Bowel Dis vol. 16, (6) 947-952.

Rao A, Tshuma NB, Goodhand JR, Wahed M, Croft NM, Epstein J, Sanderson IR (2010). RESPONSE TO AZATHIOPRINE IN ADULTS AND CHILDREN WITH INFLAMMATORY BOWEL DISEASE IS COMPARABLE WHEN PHENOTYPE IS CONTROLLED. J PEDIATR GASTR NUTR. vol. 50, E112-E112.

Wilson DC, Thomas AG, Croft NM, Newby E, Akobeng AK, Sawczenko A, Fell JME, Murphy MS et al.(2010). Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr vol. 50 Suppl 1, S14-S34.

Goodhand J, Tang JW, Naik S, Croft N, Lindsey JO (2009). Infliximab Use in Adolescents with Inflammatory Bowel Disease. GASTROENTEROLOGY. vol. 136, A657-A657.

Goodhand J, Tang J, Naik S, Croft NM, Lindsay JO (2009). INFLIXIMAB USE IN ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE. GUT. vol. 58, A63-A64.

Newby EA, Croft NM, Green M, Hassan K, Heuschkel RB, Jenkins H, Casson DH(2008). Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr vol. 46, (5) 539-545.

Dawson R, Hefferon M, Croft N, Lindsay JO(2008). IBD in adolescents: A case control study of disease extent and therapeutic strategy. GASTROENTEROLOGY vol. 134, (4) A506-A506.

Croft NM(2008). Gluten-free diets in celiac disease: does life mean life?. Gastroenterology vol. 134, (3) 883-885.

Naik S, Smith F, Ho J, Croft NM, Domizio P, Price E, Sanderson IR, Meadows NJ(2008). Staphylococcal enterotoxins G and I, a cause of severe but reversible neonatal enteropathy. Clin Gastroenterol Hepatol vol. 6, (2) 251-254.

Seerat I, Croft NM, Hickey A, Longhurst H (2008). IGG antibodies to foods are of no relevance to IGE mediated food allergy. GUT. vol. 57, A87-A87.

Croft NM(2008). Ulcerative and Indeterminate Colitis. Walker's pediatric gastrointestinal disease, Editors: Kleinman, RE, Goulet, O, Sanderson, IR, Sherman, PM et al., Edition. 5th Revised edition, B.C. Decker (Hamilton),

Karuppaswamy S, Croft N (2007). A case of multiple food allergies. CLINICAL AND EXPERIMENTAL ALLERGY. vol. 37, 1876-1876.

Daley A, Randall R, Darsley M, Choudhry N, Thomas N, Sanderson IR, Croft NM, Kelly P(2007). Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation. Gut vol. 56, (11) 1550-1556.

Di Sabatino A, Pickard KM, Gordon JN, Salvati V, Mazzarella G, Beattie RM, Vossenkaemper A, Rovedatti L et al.(2007). Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology vol. 133, (4) 1175-1187.

Croft N, MACDONALD T, Monteleone G, Troncone R, Corazza GR, Stagg AG, Leakey NAM, Vossenkaemper A et al.(2007). Evidence for the role of interferon-Ą production by dendritic cells in the Th1 response in celiac disease. Gastroenterology vol. 133, 1175-87.

Croft NM(2007). Biologicals move into the esophagus. Gastroenterology vol. 133, (1) 358-360.

Beattie RM, Croft NM, Fell JM, Afzal NA, Heuschkel RB(2006). Inflammatory bowel disease. Arch Dis Child vol. 91, (5) 426-432.

Afzal NA, Hans-Joerg L, Mills S, Green M, Naik S, Meadows N, Sanderson I, Croft N (2006). Inflammatory bowel disease phenotype in British children of South Asian origin. GASTROENTEROLOGY. vol. 130, A215-A215.

Croft NM(2006). Phospholipid in UC: novel, safe and works--is it too good to be true?. Gastroenterology vol. 130, (3) 1003-1004.

Sawczenko A, Azooz O, Paraszczuk J, Idestrom M, Croft NM, Savage MO, Ballinger AB, Sanderson IR(2005). Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci U S A vol. 102, (37) 13260-13265.

Croft NM, Hodges M(2005). IgM: mucosal response in acute diarrhoeal disease of infants. Scand J Gastroenterol vol. 40, (8) 965-971.

Sanderson IR, Croft NM (2005). The anti-inflammatory effects of enteral nutrition. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION. vol. 29, S134-S140.

Ho J, Croft N, Akanle A (2005). Bone mineral density at diagnosis in paediatric inflammatory bowel disease. BONE. vol. 36, S86-S86.

Dogra H, Kruidenier L, Croft NM, Sanderson IR, Wilson JW (2005). Butyrate regulates the expression of the intestinal epithelial stem cell marker, Musashi-1. GASTROENTEROLOGY. vol. 128, A279-A279.

Croft NM(2005). IgG food antibodies and irritating the bowel. Gastroenterology vol. 128, (4) 1135-1136.

Dogra H, Kruidenier L, Sanderson IR, Croft NM, Wilson JW (2005). Luminal regulation of intestinal epithelial stem cell fate. GUT. vol. 54, A78-A78.

Sawczenko A, Idestrom M, Ballinger AB, Croft NM, Sanderson IR (2005). The -174 G/c interleukin-6 polymorphism determines growth failure in paediatric onset Crohn's disease. GASTROENTEROLOGY. vol. 128, A39-A39.

Sawczenko A, Idestrom M, Ballinger AB, Croft NM, Sanderson IR (2005). The-174 G/C interleukin-6 polymorphism determines growth failure in paediatric onset Crohn's disease. GUT. vol. 54, A97-A98.

Croft NM(2004). The spice of life for cystic fibrosis. Gastroenterology vol. 127, (5) 1639-1640.

Arthur SK, Nadeem A, Rawat D, Smith F, Wiles K, Croft N, Evans DF, Meadows N (2004). An appraisal of the impact of manometry on the management of children with feeding difficulties. GUT. vol. 53, A62-A62.

Yazaki E, Hirata M, Rawat D, Croft N, Meadows N, Evans DF (2004). Can electrogastrography replace gastric emptying for children with gastric dysfunction?. GUT. vol. 53, A113-A113.

Croft NM, Paraszczuk J, Ali E, Wilson JW, Jones SA, Naik S, Sanderson IR (2004). Is there a relationship between NOD2 polymorphism and response to polymeric enteral feed in children with Crohn's disease?. GUT. vol. 53, A32-A32.

Daley AC, Croft N, Randall R, Kelly P (2004). Lack of a systemic immune response to oral vaccination does not indicate lack of mucosal immunity. GUT. vol. 53, A72-A72.

Bannerjee K, Camacho-Hübner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, Sanderson IR, Croft NM(2004). Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr vol. 38, (3) 270-275.

Escher JC, European Collaborative Research Group on Budesonide in Paediatric IBD(2004). Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial. Eur J Gastroenterol Hepatol vol. 16, (1) 47-54.

Akanle OA, Ho J, Muhiddin K, Admans L, Croft NM, Spyrou NM(2004). Elemental composition of hair and bone density measurements at diagnosis in paediatric inflammatory bowel disease. J RADIOANAL NUCL CH vol. 259, (2) 355-360.

Fuchs G, Ahmed T, Araya M, Baker S, Croft N, Weaver L (2004). Malnutrition: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. vol. 39, S670-S677.

Croft NM, Ho J, Akanle OA, Savage MO, Sanderson IR (2003). Decreased bone mineral density at diagnosis in paediatric inflammatory bowel disease. GUT. vol. 52, A21-A21.

Naik S, Smith F, Ho J, Croft NM, Domizio P, Price E, Sanderson IR, Meadows NJ (2003). Staphylococcal enterotoxin G and I: A novel cause of severe neonatal enteropathy?. GUT. vol. 52, A101-A101.

Naik Z, Smith F, Ho J, Croft N, Domizio P, Sanderson I, Meadows T, Price E (2003). Staphylococcal enterotoxins G and I: A cause of severe neonatal enteropathy?. GASTROENTEROLOGY. vol. 124, A560-A560.

Sawczenko A, Ballinger AB, Croft NM, Sanderson IR, Savage MO(2003). Adult height in patients with early onset of Crohn's disease. Gut vol. 52, (3) 454-455.

CROFT NM, Pender SL, Salvati M, Monteleone G, Holloway J, Fairclough PD, MacDonald TT(2003). Activated STAT4 and a functional role for IL-12 in human Peyer's patches. J. Immunol. vol. 170, (1) 300-307.

CROFT NM(2003). Management of Crohn's disease in children. Management of Crohn's disease; Greig ER, Rampton DS, eds., Martin Dunitz (London and New York),

Ali E, Crouchman P, Meadows N, Sanderson IR, Croft NM (2002). Outcome of enteral feeding for newly diagnosed Crohn's disease. GUT. vol. 50, A71-A72.

Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT(2001). Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J Clin Invest vol. 108, (4) 601-609.

Thapar N, Croft N, Meadows N, Evans D (2001). Achalasia in children: An increasing problem? Endoscopic use of botulinum toxin and experience from a single UK centre. GASTROINTEST ENDOSC. vol. 53, AB204-AB204.

Kelly EJ, Naik S, Sanderson IR, Croft NM (2001). Elemental diet modulates the inflammatory response of enterocytes. GASTROENTEROLOGY. vol. 120, A674-A675.

Croft NM(2001). Intestinal inflammation in cystic fibrosis. ARCH DIS CHILD vol. 84, (4) 374-375.

Thapar N, Croft NM, Meadows N, Evans D (2001). Achalasia in children: An increasing and more severe problem? A single centre experience. GUT. vol. 48, A91-A91.

Croft NM, Kelly EJ, Bannerjee K, Dryhurst K, Sanderson I (2001). Diets can modulate the inflammatory response in vivo and in vitro. GUT. vol. 48, A2-A2.

Ballinger AB, Camacho-Hübner C, Croft NM(2001). Growth failure and intestinal inflammation. QJM vol. 94, (3) 121-125.

Kumberova A, CROFT NM, MacDonald TT, Steer HW, Monteleone G, McKenzie C(2001). Blocking Smad7 restores TGF-beta1 signalling in chronic inflammatory bowel disease. J. Clin. Invest. vol. 108, (4) 601-609.

CROFT NM(2001). Current treatment of IBD in children. [Review]. Hospital Prescriber Europe vol. 2, 29-31.

Croft NM, Howatson AG, Ling SC, Nairn L, Evans TJ, Weaver LT(2000). Microvillous inclusion disease: an evolving condition. J Pediatr Gastroenterol Nutr vol. 31, (2) 185-189.

Smyth RL, Croft NM, O'Hea U, Marshall TG, Ferguson A(2000). Intestinal inflammation in cystic fibrosis. Archives of Disease in Childhood vol. 82, (5) 394-399.

Bannerjee K, Croft NM, Babinska K, Camachno-Hubner C, Savage MO, Sanderson IR (2000). The influence of enteral feeding on growth factors, inflammation and nutrition in children with Crohn's disease. GASTROENTEROLOGY. vol. 118, A64-A64.

Croft NM, Ferguson A(2000). High intraluminal fluid flow increases intestinal IgA output. Scandinavian Journal of Gastroenterology vol. 35, (7) 726-731.

Croft N, Heaf D(1996). Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis - Discussion. POSTGRADUATE MEDICAL JOURNAL vol. 72, S36-S36.

Croft NM, Marshall TG, Ferguson A(1996). Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis. Postgrad Med J vol. 72 Suppl 2, S32-S36.

Croft NM, Marshall TG, Ferguson A(1996). Gut inflammation in children with cystic fibrosis on high-dose enzyme supplementation - Reply. LANCET vol. 347, (8997) 327-327.

Croft NM, Marshall TG, Ferguson A(1995). Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements. Lancet vol. 346, (8985) 1265-1267.

Ferguson A, Humphreys KA, Croft NM(1995). Technical report: results of immunological tests on faecal extracts are likely to be extremely misleading. Clin Exp Immunol vol. 99, (1) 70-75.

Croft NM, Jacob AJ, Godman MJ, Boon NA, Mok JY(1993). Cardiac dysfunction in paediatric HIV infection. J Infect vol. 26, (2) 191-194.

Lyall EG, Langdale-Brown B, Eden OB, Mok JY, Croft NM(1993). Ewing's sarcoma in a child with human immunodeficiency virus (type 1) infection. Med Pediatr Oncol vol. 21, (2) 127-131.

Croft N, Yap PL, Mok JY, Hague RA, Burns SM(1992). Zidovudine therapy in combination with intravenous immunoglobulin in HIV infected children. Scott Med J vol. 37, (5) 138-141.